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Research
On 11 September 2001 (9/11), lower 
Manhattan and parts of Brooklyn were 
engulfed by a dense cloud of toxic and irri-
tant dust and smoke generated by the collapse 
of the World Trade Center (WTC) towers 
(Landrigan et al. 2004; Levin et al. 2002; Lioy 
et al. 2002). This cloud comprised a complex 
mix of pollutants, among them the products 
of combustion of 91,000 L jet fuel, pulver-
ized building materials, cement dust, asbestos, 
microscopic shards of glass, silica, heavy met-
als, and numerous organic compounds [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901159)] (Edelman et al. 2003; McGee 
et al. 2003; Prezant et al. 2002; Reibman et al. 
2005).
Adverse health effects have developed since 
9/11 in workers and volunteers involved in the 
rescue, relief, and cleanup at the WTC site and 
at the Staten Island landfill (the major wreck-
age depository) (Edelman et al. 2003; Herbert 
et al. 2006; Landrigan et al. 2004; Lioy et al. 
2002; Prezant et al. 2002). The health effects 
most commonly observed involved the upper 
and lower respiratory tract. Signs, symptoms, 
and findings include persistent cough, breath-
lessness, wheezing, asthma, sinusitis, laryngitis, 
and irritant-induced asthma, also named reac-
tive airways dysfunction syndrome (RADS) 
(Herbert et al. 2006; Levin et al. 2002; 
Prezant et al. 2002). Cases of interstitial lung 
disease have also been reported, including acute 
eosinophilic pneumonia, granulomatous pneu-
monitis, sarcoidosis, and bronchiolitis oblit-
erans (Izbicki et al. 2007; Mann et al. 2005; 
Rom et al. 2002; Safirstein et al. 2003).
The  Mount  Sinai  WTC  Medical 
Monitoring and Treatment Program (MMTP) 
was established to provide standardized 
screening and facilitate treatment of eligible 
responders who worked or volunteered at 
the WTC site. There is no systemic or com-
prehensive roster of all responders similar to 
the existing records of responders from the 
New York City uniformed services, such as 
the Fire Department of New York (FDNY) 
or New York Police Department, which fre-
quently include their previous health condi-
tion. Estimates of the number of responders 
given by different sources range from 50,000 
to 90,000 in total; we believe that the total, 
including FDNY workers, is likely to have 
been between 60,000 and 70,000 (Moline 
et al. 2009). In this article, we report on a case 
series of seven WTC responders enrolled in 
the Mount Sinai WTC MMTP who under-
went video-assisted thoracoscopic (VATS) pro-
cedures at the Mount Sinai Medical Center 
and whose WTC exposures began on either 
11 September or 12 September 2001. As of 
11 September 2007, a total of 12,891 respond-
ers claiming first- and/or second-day exposure 
to the WTC pile had monitoring examina-
tions at the Mount Sinai MMTP on or before 
11 September 2007. Of these responders, 
one underwent VATS with biopsy in 2005, 
and six underwent VATS procedures between 
1 January and 31 October 2007, because of 
severe pulmonary symptoms, impairment, or 
unexplained radiologic findings. We describe 
here the histopathologic patterns associ-
ated with these severe forms of respiratory 
  impairment.
As part of our overall biopsy examination, 
we performed mineralogic analyses of the tis-
sue from seven individuals believed to have 
been previously healthy who developed signs 
of respiratory impairment after sustaining 
WTC exposures. Additionally, we obtained 
and analyzed dust specimens collected on 
the site (DS) and examined old specimens 
(controls for old cases; COC) unrelated to the 
WTC disaster that were routinely submitted 
to our laboratory for asbestos burden analysis 
(n = 40) or obtained for research purposes 
from autopsy or surgical specimens (n = 20) of 
patients without history of WTC exposure. 
Material and Methods
Patients. All seven patients included in 
this study had either never smoked or had 
smoked only in the remote past. They were 
Address correspondence to M. Wu, Mount Sinai 
School of Medicine, Box 1194, One Gustave L. Levy 
Place, New York, NY 10029 USA. Telephone: (212) 
241-1822. Fax: (212) 534-6574. E-mail: maoxin.
wu@mssm.edu
*Current address: Department of Surgery, University 
of Rochester Medical Center, Rochester, NY.
Supplemental  Material  is  available  online 
(doi:10.1289/ehp.0901159 via http://dx.doi.org/).
We thank P. Landrigan for manuscript review, 
R. de la Hoz for insightful clinical work, L. Crowley 
for manuscript review, G. Shukla for literature 
review, E. Call and R. Oxman for manuscript prepa-
ration, and J. Samet for photographic assistance.
This publication was made possible by Centers for 
Disease Control and Prevention (CDC) and National 
Institute for Occupational Safety and Health 
(NIOSH) grants 5U1O 0H008232-04 (World Trade 
Center Data and Coordination Center) and 3U10 
OH008225 (World Trade Center Clinical Center). 
The contents are the sole responsibility of the 
authors and do not necessarily represent the official 
views of the CDC/NIOSH.
The authors declare they have no competing 
  financial interests.
Received 1 July 2009; accepted 4 December 2009.
Case Report: Lung Disease in World Trade Center Responders  
Exposed to Dust and Smoke: Carbon Nanotubes Found in the Lungs  
of World Trade Center Patients and Dust Samples
Maoxin Wu,1 Ronald E. Gordon,1 Robin Herbert,2 Maria Padilla,3 Jacqueline Moline,2 David Mendelson,4 
Virginia Litle,5* William D. Travis,6 and Joan Gil1
1Department of Pathology, 2Department of Community and Preventive Medicine, 3Division of Pulmonary and Sleep Medicine, 
4Department of Radiology, and 5Department of Thoracic Surgery, Mount Sinai School of Medicine, New York, New York, USA; 
6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
co n t e x t: After the collapse of the World Trade Center (WTC) on 11 September 2001, a dense cloud 
of dust containing high levels of airborne pollutants covered Manhattan and parts of Brooklyn, New 
York. Between 60,000 and 70,000 responders were exposed. Many reported adverse health effects.
ca s e p r e s e n t a t i o n: In this report we describe clinical, pathologic, and mineralogic findings in 
seven previously healthy responders who were exposed to WTC dust on either 11 September or 
12 September 2001, who developed severe respiratory impairment or unexplained radiologic findings 
and underwent video-assisted thoracoscopic surgical lung biopsy procedures at Mount Sinai Medical 
Center. WTC dust samples were also examined. We found that three of the seven responders had 
severe or moderate restrictive disease clinically. Histopathology showed interstitial lung disease con-
sistent with small airways disease, bronchiolocentric parenchymal disease, and nonnecrotizing granu-
lomatous condition. Tissue mineralogic analyses showed variable amounts of sheets of aluminum 
and magnesium silicates, chrysotile asbestos, calcium phosphate, and calcium sulfate. Small shards of 
glass containing mostly silica and magnesium were also found. Carbon nanotubes (CNT) of various 
sizes and lengths were noted. CNT were also identified in four of seven WTC dust samples.
discussion: These findings confirm the previously reported association between WTC dust expo-
sure and bronchiolar and interstitial lung disease. Long-term monitoring of responders will be 
needed to elucidate the full extent of this problem. The finding of CNT in both WTC dust and 
lung tissues is unexpected and requires further study.
key w o r d s : bronchiolitis, carbon nanotubes, interstitial lung disease, small airway disease, WTC. 
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exposed to WTC dust/smoke beginning on 
either 11 September or 12 September 2001, 
and were sufficiently ill to undergo VATS 
biopsy. The decision to pursue a VATS biopsy 
was made by their attending pulmonolo-
gist, based on poor respiratory function with 
high-resolution computerized tomography 
(HRCT) changes suggestive of interstitial dis-
ease, marked worsening of the patient’s con-
dition, or any nodular radiologic patterns. 
All patients signed release forms authorizing 
research studies and were again contacted to 
confirm their willingness to participate. The 
patients continue to be followed. Permission 
for publication was obtained from the Mount 
Sinai Medical School Institutional Review 
Board (07-0788 0001 01 PA X).
Clinico-pathologic workup. The following 
information was obtained from the medical 
records: age, sex, occupation, smoking his-
tory, comorbidities, WTC exposure (starting 
date and length of time of exposure, whether 
caught in the original dust cloud from the 
WTC building collapse on 11 September), 
chief complaints at presentation, pulmonary 
function tests (PFTs) including forced expira-
tory volume in 1 sec (FEV1) and forced vital 
capacity (FVC), diffusing capacity of the lung 
for carbon monoxide (DLCO), and HRCT 
findings before biopsy and serologies for auto-
immune disease.
After it had been determined that a VATS 
biopsy was needed, wedges of lung from the 
right upper, middle, and lower lobes were 
obtained and submitted to the pathology ser-
vice of Mount Sinai Hospital. These speci-
mens were processed for light microscopy, 
following the routine procedures of surgical 
pathology specimens stained with hematoxy-
lin and eosin, and diagnosed by pathologists 
from the hospital service. Later, all three ana-
tomic pathologists in this study (M.W., J.G., 
and W.T.) jointly reviewed all biopsies.
Electron microscopy mineralogic analysis. 
A representative block of paraffin-embedded 
tissue was taken from each case and digested 
for mineralogic and asbestos fiber burden 
analysis. The paraffin was removed from the 
tissue and the hydrated lung tissue was blot-
ted and weighed. The tissue was then sub-
merged in potassium hydroxide for digestion. 
The digested tissue was centrifuged to sepa-
rate the nonsolubilized materials from reagents 
and solubilized materials. The precipitate was 
washed five times with distilled water. The 
digested lung material was resuspended in 
10 mL distilled water, and 10-µL samples were 
removed from each and placed on formvar-
coated nickel grids. The grids were analyzed 
by transmission electron microscopy using 
a standard fiber-counting protocol. Positive 
and negative control samples were prepared 
from the same distilled water used to wash the 
sample. Verification techniques of fiber count-
ing were used for quality control and quality 
assurance. A total of 400 grid openings were 
scanned for each lung specimen on at least 
four separate grids at magnifications of either 
10,000 or 20,000. The fibers, if present, were 
counted. All other structures were identified 
morphologically and by energy-dispersive spec-
troscopy (EDS) and counted. Chrysotile asbes-
tos was confirmed by EDS and selected area 
electron diffraction. Identification of carbon 
nanotubes (CNT) was based on comparison 
with a positive control sample provided by 
A. Shvedova from the National Institute for 
Occupational Safety and Health (NIOSH) 
and on the images and descriptions found in 
two publications (Lam et al. 2006; Poland 
et al. 2008). Seven DS collected at differ-
ent sites of the WTC (generously provided 
by R. Nolan, Environmental Sciences, City 
University of New York) were also observed by 
analytic electron microscopy for the presence 
of structures, particularly CNT. In addition, 
we retrospectively looked at 40 COC—recent, 
previously analyzed cases of construction work-
ers (carpenters, electricians, laborers, plumbers) 
believed to have been exposed to the inhalation 
of asbestos fibers, evaluated for asbestos burden, 
and found to be positive for that substance. To 
assess background levels in persons with no his-
tory of ever being exposed to asbestos or WTC 
dust, we also reevaluated 20 lung tissue samples 
from either lung resections or autopsies used to 
study for research purposes. Therefore, the total 
of reevaluated old cases was 60.
Results 
Case reports. A summary of patient clinical, 
WTC exposure, PFT findings and radiologic 
findings on HCRT imaging is presented in 
Supplemental Material, Table 2 (doi:10.1289/
ehp.0901159). Table 1 summarizes the 
pathologic/mineralogic/asbestosis fiber bur-
den analysis. All patients affirmed that their 
symptoms had developed after the 9/11 attack 
and denied history of asthma or of any other 
significant pulmonary conditions except as 
shown for Patient B. 
Patient A. Patient A is a 59-year-old 
female nurse who was caught in the dust cloud 
for 4 hr on 9/11. She also lives three blocks 
from the WTC site. She worked on the pile 
or in the pit at the WTC site for 41 days, or 
352 hr, giving first aid to workers and pedes-
trians. The patient presented to the WTC 
MMTP in November 2006 with shortness of 
breath, hoarseness, cough, wheezing, and chest 
tightness. After 11 September, she developed 
asthma, bronchitis, and pneumonia. Her past 
medical history is significant only for hypo-
thyroidism. The patient is a nonsmoker.
PFTs (8 August 2007) were consistent with 
severe restrictive lung disease, with FVC 46%, 
FEV1 51%, and DLCO 38%. HRCT revealed 
interstitial fibrosis with a subpleural distri-
bution with prominent mediastinal nodes. 
Lung biopsy showed honeycombing, severe 
peripheral fibrosis, and peribronchiolar usual 
interstitial pneumonitis (UIP)-like fibrosis 
(Figure 1B; Supplemental Material, Figure 1B 
(doi:10.1289/ehp.0901159). Mineralogic 
analysis revealed silicates 165,600/g and CNT 
110,400/g.
The patient was last seen on 9 September 
2009 and continued to have severe dyspnea on 
effort, aggravated by early satiety and abdomi-
nal fullness. PFT showed worsening in her 
lung function, with FVC 40%, FEV1 46%, 
and DLCO 29%. CT scan of chest revealed 
progression of interstitial fibrosis and decreased 
lung volumes. The patient has been referred for 
lung transplant, but active lung transplant list-
ing has been postponed because of her subjec-
tive well-being and physical appearance despite 
progression of disease.
Patient B. This patient is a 59-year-old 
male who worked as an electrician. He arrived 
Table 1. Summary of findings in pathology and minerologic/asbestos fiber burden analyses. 
Patient Pathologic summary
Mineralogic and asbestos 
fiber burden analysis
A UIP-like, HP-like AS and MS: 165,600/g
CNT: 110,400/g
B UIP-like, NSIP-like AS and MS: 165,600/g
CNT: 3,450/g
C NSIP-like (cellular > fibrosing) CA: 36,800/g
AS and MS: 184,000/g
CNT: 230,000/g
D Mild chronic bronchiolitis; occasional peribronchiolar and 
submucosal fibrosis
CA: 5,520/g
AS and MS: 27,600/g
CNT: 11,040/g
CS: large amount
E UIP-like, HP-like CA: 110,400/g
AS and MS: 110,400/g
F Peribronchiolar metaplasia and respiratory bronchiolitis CA: ND
AS, CS, CNT: ND
G Sarcoid-like CA: 11,829/g
MS: 63,086/g
Abbreviations: AS, aluminum silicate; CS, calcium sulfate; CA, chrysotile asbestos; HP, hypersensitivity pneumonia; MS, 
magnesium silicate; ND, none detected; NSIP, nonspecific interstitial pneumonitis; UIP, usual interstitial pneumonitis.Carbon nanotubes and complex histopathologic patterns found in early WTC responders
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at the WTC site on day 1 and worked for 
90 days, or 1,080 hr, adjacent to the pile/pit. 
He worked as an engineer at the site repairing 
and accessing damage to signals, generators, 
and power cables for New York City transit. 
He presented to MMTP in March 2006 with 
complaints of dyspnea, cough, throat irrita-
tion, and wheezing. He has a past medical 
history of pneumothorax, “cyst in the lung,” 
and arrhythmia. After 9/11, he developed sleep 
apnea (on continuous positive airway pressure). 
The patient is a nonsmoker.
PFTs are consistent with a mild restric-
tive and obstructive pattern, along with oxy-
gen desaturation with exercise (97%–90%). 
His chest radiograph revealed nodules. 
HRCT (6 November 2006) revealed multiple 
small nodules (seven), prominent interstitial 
markings, and bronchiectasis. Lung biopsy 
showed interstitial fibrosis, mostly bronchiolo-
centric, with multiple patterns consistent with 
UIP, nonspecific interstitial pneumonitis 
(NSIP) [Supplemental Material, Figure 1F 
(doi:10.1289/ehp.0901159)], and hyper-
sensitivity pneumonitis. Mineralogic analysis 
revealed CNT 3,450/g, silicates 165,600/g, 
and no asbestos fibers
At a follow-up visit in 18 September 2009, 
the patient complained of shortness of breath, 
which remained unchanged, and worsening 
joint pain. His PFTs were FVC 86%, FEV1 
80%, and DLCO 82%. The patient was referred 
to a rheumatologist, and standard tests for auto-
immunity were negative. Oxygen desaturation 
is still present but has improved: 98%–93%. 
CT scan of the chest shows mild worsening of 
the interstitial markings. Bronchiectasis and 
nodules are unchanged.
Patient C. Patient C is a 49-year-old 
male who worked in building trades, who 
presented in February 2007 with com-
plaints of cough since 2005 and dyspnea 
on exertion. He worked adjacent to the pile 
10–12 hr/day for 8 days after 9/11 (102 hr) 
as a custodian at the WTC site, covering up 
vents and sweeping out dust. He has a past 
medical history of myocardial infarction. He 
is a nonsmoker.
PFTs (23 August 2007) were consistent 
with severe restrictive lung disease, with FVC 
49%, FEV1 50%, and DLCO 34%. HRCT 
reveals subpleural interstitial linear and ground 
glass changes. Enlarged lymph nodes were also 
present. Lung biopsy showed peribronchiolar 
fibrosis [Supplemental Material, Figure 1D 
(doi:10.1289/ehp.0901159)], NSIP-type, with 
extensive lymphocytic infiltrates and bronchi-
olitis. Mineralogic analysis revealed chrysotile 
asbestos 36,800/g; silicates 184,000/g, and 
CNT 230,000/g.
This patient was last seen 2 March 2009 
and continues to have limited functional 
capacity, with continued dyspnea on exertion 
(DOE) and overall disease progression. He 
is on immuno  suppressive medication. PFTs 
show FVC 41%, FEV1 45%, and DLCO 
34%. HRCT shows progression of paren-
chymal disease.
Patient D. This patient is a 40-year-old 
male health care worker who was caught in the 
dust cloud of the WTC collapse. He worked 
on the WTC site from 11 September 2001 
until February 2002, for a total of 1,080 hr. 
He worked on the pile/pit and the office of 
chief medical examiner (OCME), digging on 
the pile and identifying remains in the morgue. 
He presented in May 2006 with 3 years of 
DOE, dry cough, sore throat, hoarseness, 
wheezing, worsening gastro  esophageal reflux 
(GERD), and diarrhea. After 11 September 
2001, the patient developed sleep apnea, 
chronic bronchitis, vocal cord dysfunction, 
posttraumatic stress disorder, chest pain, dif-
ficulty breathing, heartburn, unstable angina, 
GERD, shortness of breath, and cough. The 
patient is a nonsmoker.
PFTs before VATS biopsy showed mild 
to moderate restrictive lung disease, with 
FVC 65% and FEV1 70%; DLCO was not 
available. HRCT revealed a mosaic lung (air 
trapping) (Figure 2A). Lung biopsy showed 
bronchiolitis [Supplemental Material, 
Figure 1A (doi:10.1289/ehp.0901159)], and 
mild peribronchiolar fibrosis (Figure 1A). 
Mineralogic analysis revealed CNT 11,040/g, 
silicates 27,600/g (plus calcium sulfate in large 
amounts), and chrysotile asbestos 5,520/g.
Patient D was last seen in follow-up in 
July 2008 and continued to complain of sig-
nificant DOE. Cardiopulmonary exercise 
testing, PFTs, and oxygen saturation were 
normal.
Patient E. The patient is a 46-year-old 
female law enforcement officer. She was 
caught in the original cloud and worked on 
9/11 for 12 hr. She worked adjacent to the 
pile/pit and the OCME for a total of 41 days, 
or 352 hr. The patient stated that her main 
activities at the WTC site included working 
at the morgue. The patient presented to the 
MMTP in October 2004 with complaints of 
shortness of breath and dyspnea on effort with 
some chest pain and wheezing. The patient is 
a nonsmoker.
After 11 September 2001, the patient 
developed asthma, breathing problems, 
and dysphagia. PFTs revealed an FVC of 
65%, FEV1 69%, and DLCO 46%. HRCT 
revealed peripheral changes suggestive of UIP 
[Figure 2B; see also Supplemental Material, 
Figure 1C (doi:10.1289/ehp.0901159)]. 
Lymph nodes were mildly enlarged. 
Mineralogic analysis revealed chrysotile 
asbestos 110,400/g and 110,400/g silicates. 
Lung biopsy showed focal areas of fibrosis 
with fibroblastic foci small granulomas, non-
necrotizing, and peribronchiolar lesions. 
Airways contained mucopurulent material.
She was last seen by her pulmonologist in 
June 2009, with stable complaints. Her CT 
scan findings from November 2008 are stable 
compared with February 2006, as were her 
PFTS. Resting oxygen saturation was 98%.
Patient F. Patient F is a 55-year-old 
female custodian and asbestos handler. She 
worked adjacent to the pile/pit on the WTC 
site from 12 September to 23 November for 
660 hr. She worked as a custodian and in 
Figure 1. Light photomicrographs of representative histopathology of patient lung tissue of the three groups. Bar = 10 µm. (A) Honeycomb fibrosis, Patient A. There 
is extensive dense fibrosis with cystic remodeling of the lung parenchyma. The cysts are lined by pseudostratified respiratory epithelium, and are either empty 
or filled with mucous and/or inflammatory cells. A bronchiole is seen in the center near the artery. (B) Chronic bronchiolitis, Patient D. There is marked chronic 
inflammation in the submucosa with interstitial clusters of macrophages and metaplasia of the respiratory epithelium. (C) Granuloma, Patient G. Poorly formed 
nonnecrotizing granulomas in interstitium.
A C BWu et al.
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dust suppress at the WTC site. In October 
2003, the patient presented with dry cough, 
wheezing, decreased exercise tolerance, and 
sleep apnea. Her past medical history is non-
contributory. The patient is a former smoker 
(31 pack-years).
PFTs are consistent with normal spirometry 
and diffusing capacity. HRCT demonstrated 
marked mosaic pattern consistent with air trap-
ping, as well as old calcified granuloma. Lung 
biopsy showed small airways disease, respiratory 
bronchiolitis [Supplemental Material, Figure 
1E (doi:10.1289/ehp.0901159)], peribronchial 
bronchiolar metaplasia. Lung parenchyma was 
unremarkable. Mineralogic analysis showed no 
relevant findings.
Patient F was last seen in June 2009. She 
continued to have significant upper respira-
tory complaints, along with increased cough, 
chest tightness and wheezing, sinusitis, and 
generalized pain. She is disabled.
Patient G. Patient G is a 55-year-old male 
law enforcement officer who worked on the 
WTC site on 11 September for 18 hr. The 
patient worked on and adjacent to the pile/
pit, and his main activities included working 
in bucket brigade and security at the WTC 
site. The patient initially complained of dys-
pnea on exertion, cough, wheezing, and chest 
tightness. The patient is a nonsmoker.
PFTs revealed minimal restriction and a 
positive bronchodilator response consistent 
with RADS. HRCT revealed multiple nodes 
(Figure 2C), some calcified, and peribronchial 
interstitial disease. Lung biopsy shows non-
necrotizing epithelioid granulomas (Figure 1C) 
and small airways disease. Mineralogic analy-
sis reveals magnesium silicate 63,086/g and 
chrysotile asbestos 11,829/g.
This patient was last seen in July 2009 
with complaints of worsening cough and 
shortness of breath. HRCT shows a miliary 
pattern of innumerable tiny nodular densities 
in both lungs. Multiple small calcified lymph 
nodes in mediastinum, fibrous bands, and 
ground glass areas were also seen. A gallium 
scan shows faint uptake in hilum but none in 
parenchyma. He was evaluated for sarcoidosis 
with negative results. A Kveim test was nega-
tive. No subsequent manifestations consistent 
with sarcoidosis have been noted.
Electron microscopy mineralogic find-
ings. A summary of the mineralogic analy-
sis in correlation with pathologic features is 
given in Table 1. Four of the seven WTC dust 
samples contained CNT. The lung specimens 
of three of the patients with interstitial dis-
ease (Patients A, B, and C) contained CNT 
(Figure 3A) virtually identical to those of the 
dust samples (Figure 3B) and of the positive 
control sample (Figure 3C). CNT seen were 
all single-walled and of various lengths. They 
were mostly ropelike under electron micros-
copy. The fourth patient with CNT had mild 
chronic bronchiolitis and occasional peribron-
chiolar and submucosal fibrosis (Patient D). 
The nanotubes identified in patient lung sam-
ples appear mostly in single or pairs. The single 
nanotubes are indicated by arrows in all graphs 
of Figure 3. Most CNT seen in the CNT-
positive control and WTC dust samples were 
stacks of single nanotubes, thus appearing to 
be variable in thickness. No CNT were found 
in the lungs of either the 40 construction 
workers or the 20 negative control samples.
Of the patients with interstitial disease, all 
had large amounts of aluminum and magne-
sium silicates in an unusual platy configura-
tion, ranging from 27,600 to 184,000/g wet 
weight of lung. As a comparison, we reexam-
ined for the presence of CNT in 40 samples 
taken from unrelated workers from diverse con-
struction trades suspected for asbestos-related 
disease. These patients were known to have 
been exposed to asbestos, and most of these 
40 patients had a high lung burden of asbes-
tos fibers. Less than 10%, however, had platy 
aluminum and magnesium silicates similar 
to those seen in WTC patients. Furthermore 
when they were seen in the control samples, 
they were present in small quantities (< 1,000/g 
wet weight of lung).
Discussion
In this case report, we describe seven previ-
ously healthy WTC responders who devel-
oped lung disease after sustaining heavy 
first- and second-day exposures to WTC dust 
and debris. We summarize our findings as 
follows: a) CNT were found in some WTC-
exposed patients with persistent lung disease 
with confirmation by positive controls and 
in the WTC dust. This finding was pres-
ent in responders with extensive interstitial/ 
parenchymal abnormalities (three of four 
patients) and in one of two patients with small 
airway disease, but not in the patient with 
nonnecrotizing granulomas. b) We found a 
higher amount of aluminum silicate and mag-
nesium silicate in all four patients with dif-
fuse interstitial/parenchymal abnormalities 
compared with those with small airway dis-
ease and granuloma. Chrysotile asbestos fibers 
were also found in four of seven patients in 
quantities modestly higher than background 
levels of asbestos in the New York City popu-
lation. In interpreting these findings, however, 
it should be noted that mineralogic analysis of 
the lungs can be biased because of sampling 
variability within the lung itself.
The seven biopsies revealed multiple, partly 
repeating and mixed histologic patterns. a) 
Small airways disease was present in almost 
all cases at different levels of severity, and we 
highlight patients D and F, in whom it was 
the main finding. Radiologically, these two 
patients presented with a mosaic pattern indic-
ative of air trapping similar to that previously 
described in 25 WTC responders (Mendelson 
et al. 2007). Small airways disease is a condi-
tion that pathologically can be controversial 
and includes bronchiolitis (Fenton et al. 2007; 
Niewoehner et al. 1974; Wright et al. 1992). 
It may well be the most frequent injury pat-
tern in exposed patients with severe respiratory 
Figure 2. Representative HRCT images. (A) Air trapping (mosaic pattern) in Patient D (end expiratory). (B) UIP-like pattern in Patient E. (C) Sarcoid-like pattern in 
Patient G.Carbon nanotubes and complex histopathologic patterns found in early WTC responders
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impairment. b) Interstitial disease was pres-
ent in four cases (Patients A, B, C, and E), 
characterized by a generally bronchiolocentric 
pattern of interstitial inflammation and fibrosis 
of variable severity. The lungs of these patients 
contained large amounts of silicates, and three 
of them showed nanotubes. The peripheral 
alveolar remodeling and fibrosis could vari-
ably be characterized as honeycombing, UIP- 
or NSIP-like, had some fibroblastic foci, or 
even resembled hypersensitivity pneumonitis 
(which was ruled out by pertinent serologies in 
all cases). Patient E even showed small num-
bers of poorly organized granulomas in one of 
the lobes and a mediastinal lymph node. The 
number of interstitial lymphocytes was vari-
able, and some evidence of bronchiolitis was 
generally present. The bronchiolocentric char-
acteristics seem consistent with an inhalation-
related etiology. c) We had only one patient 
with the principal diagnosis of granulomatous 
disease (Patient G), although Patient E also 
revealed some small scattered granulomas. In 
the intervening years, this patient has devel-
oped evidence of interstitial disease, in the form 
of a miliary pattern of minute nodules, but no 
signs of sarcoidosis, including a negative Kveim 
test. Mineralogic studies may reflect sampling 
heterogeneity. Granulomatous disease has 
been previously described after WTC exposure 
(Izbicki et al. 2007; Safirstein et al. 2003).
Determination of the epidemiology of 
interstitial lung diseases and exact incidence 
rates remains challenging. Although several 
studies investigating incidence rates in inter-
stitial lung disease have been conducted, 
uncertainty exists because of their reliance 
on databases and diagnoses codes (Coultas 
et al. 1994; Gribbin et al. 2006; Raghu et al. 
2006). Difficulties because of changes in dis-
ease definitions and histopathologic classifica-
tions have further complicated the issue, as 
well as differences in epidemiologic design of 
studies, limited large-scale epidemiologic data 
for specific types of interstitial lung disease, 
and registration bias (Demedts et al. 2001).
We have not sought to describe the inci-
dence of interstitial disease in the WTC 
MMTP patients. The sudden onset of six 
biopsies of our cases in January 2007 and the 
unexpected end of such cases, in October of the 
same year, is likely a reflection of the availabil-
ity of federal funding for comprehensive treat-
ment for WTC responders, which only first 
became available in the MMTP in November 
2006. Patients may have sought care outside of 
the MMTP in earlier years, and some patients 
might have been too ill to visit the MMTP. 
Given these limitations, these cases are not an 
accurate representation of the time of onset. 
Whether they are an accurate representation of 
the total burden in this cohort remains to be 
seen, but it is unlikely, given the fact that phy-
sicians, including pulmonologists, have differ-
ent criteria with regard to ordering diagnostic 
tests such as CT scans, diffusion measurements, 
and VATS biopsies.
Electron microscopic mineralogic analy-
sis revealed CNT in WTC responders with 
extensive interstitial/parenchymal abnormali-
ties (three of four patients) and in one of two 
patients with small airway disease, but not in 
the patient with nonnecrotizing granulomas. 
Nanomaterials such as CNT have many poten-
tial applications in electronics, computer, and 
aerospace industries because of their desirable 
electrical, mechanical, and thermal proper-
ties (Lam et al. 2004). CNT are hydrophobic 
carbon cylinders with a diameter of a few to 
200 nm and variable length depending on their 
degree of aggregation (Florito et al. 2006; Li 
et al. 2007; Mercer et al. 2008; Murr et al. 
2005; Shvedova et al. 2008a; Tian et al. 2006). 
There are single-walled carbon nanotubes 
(SWCNT), consisting of one such cylinder, and 
multiwalled carbon nanotubes (MWCNT), 
composed of cylinders concentrically stacked 
and in the form of ropes with a common long 
axis. They can either be commercially synthe-
sized or can develop spontaneously over flames 
and high temperatures in the presence of car-
bon and a metal catalyst.
CNT of commercial origin, common now, 
would not have been present in substantial 
numbers in the WTC complex before the 
disaster in 2001. However, the high tempera-
tures generated during the WTC disaster as a 
result of the combustion of fuel in the presence 
of carbon and metals would have been suf-
ficient to locally generate large numbers of 
CNT. This scenario could have caused the gen-
eration of CNT that we have noted in the dust 
samples and in the lung biopsy specimens.
Experimental studies, both in vitro and in 
animals, show the potential toxicity of some 
types of CNT (Florito et al. 2006; Li et al. 
2007; Mercer et al. 2008; Murr et al. 2005; 
Shvedova et al. 2008a, 2008b; Tian et al. 
2006). They are believed to be proinflamma-
tory, fibrosing, and capable of inducing granu-
lomas when inhaled in mouse models (Mercer 
et al. 2008). Shvedova et al. (2008b) observed 
that inhalation of SWCNT resulted in a 
4-fold increase in fibrosis, along with collagen 
deposition, in the peribronchial and intersti-
tial areas in the lungs of mice when compared 
with exposure by aspiration of SWCNT. CNT 
introduced into the abdominal cavity of mice 
can cause asbestos-like pathogenicity (Poland 
et al. 2008). Very recently, the Berkeley 
group has shown that oxidative stress can be 
induced by zero-valent iron (Fe) nanoparticles 
and Fe(II) in human bronchial epithelial cells 
(Keenan el al. 2009), which may contribute to 
the chain reaction of oxidative damages.
There is evidence that CNT may contrib-
ute to granuloma formation, although this may 
depend on the type of CNT present. In a study 
by Lam et al. (2004), granuloma formation 
and interstitial inflammation was observed in 
four of nine mice who were administered a 
high dose (0.5 mg) of CNT compared with 
mice administered a low dose (0.1 mg) of 
CNT. Similar findings were also observed in 
a study conducted by Muller et al. (2005), 
where granulomas, completely or partially 
blocking the bronchial lumen, were observed 
in the bronchi of rats 60 days after intratracheal 
instillation of MWCNT. Additionally, ground 
MWCNT, administered to rats via intratra-
cheal instillation, were better dispersed in the 
parenchyma and also produced granulomas 
in the interstitial tissue (Muller et al. 2005). 
Shvedova et al. (2005) showed that epitheloid 
granulomas, which were rapid, progressive, 
and dose dependent, were observed at sites 
where SWCNT aggregates were deposited after 
Figure 3. Electron micrographs of CNT. These appear as tangled long transparent hairlike ropes and stacks of single-walled CNT. All three representative graphs 
were taken at a magnification of 100K. Single CNT in each graph are indicated by thin arrow. The arrowheads depict metal particles. Bar = 100 nm. (A) Digested 
patient lung tissue. (B) WTC dust sample. (C) Control sample from NIOSH.
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100 nm 80 kv
100 nm 80 kv A C BWu et al.
504  v o l u m e  118 | n u m b e r 4 | April 2010  •  Environmental Health Perspectives
pharyngeal aspiration of SWCNT in mice. 
Furthermore, diffuse interstitial fibrosis with 
alveolar thickening was also observed in areas 
distant from the site where SWCNT aggregates 
were deposited (Shvedova et al. 2005). In most 
of these studies, carbon black particles used as 
reference particles did not produce any granu-
lomas (Lam et al. 2004; Muller et al. 2005; 
Shvedova et al. 2005). However, CNT were 
not found in Patient G who had granulomas, 
perhaps because of inadequate sampling of the 
tissue. Mediastinal granulomas were described 
in prior studies by other WTC-exposed indi-
viduals (Izbicki et al. 2007).
Aluminum and magnesium silicates were 
present in six of seven patients in higher 
amounts than normally seen in construction 
workers. Although these may be related to 
construction material, some of them were in 
an unusual platy configuration rarely found 
in our COC from construction workers. 
Markedly higher levels (> 100,000/g) of alu-
minum silicate and magnesium silicate were 
found in Patients C–F.
The etiology of the conditions described 
in WTC responders cannot be fully eluci-
dated, because our analysis does not include 
toxic soluble gases. In this case report we 
identified the presence of unexpected CNT, 
silicates, and other elements, but it remains 
unclear whether any of these compounds may 
have caused the lung pathology. The com-
bination of compounds may have increased 
the likelihood that individuals would develop 
pulmonary impairment. Further surveillance 
of individuals with these exposures should 
provide us with additional answers.
The finding of carbon nanotubes in four of 
seven WTC patients in concentrations ranging 
from 11,000/g to 230,000/g of wet weight 
and in four of seven dust samples collected 
from the WTC site, although unique and 
important, cannot be construed as evidence for 
WTC exposure. Likewise, their absence should 
not be used as evidence of lack of exposure. A 
retrospective check of specimens in unrelated 
asbestos cases evaluated over the past 20 years 
was negative for CNT. Recently, however, 
small numbers of CNT have been identified 
in control specimens from the tri-state area 
(New York, New Jersey, Connecticut) at min-
imal concentrations (Gordon R, unpublished 
data). These might originate in the combus-
tion engines of automobiles (Lam et al. 2006).
Conclusion
The predominant finding of interstitial lung 
disease on pathology and presence of similar 
materials in most of the mineralogic samples 
including CNT and platy silicates suggests that 
WTC exposure may have contributed to the 
development of lung disease. Furthermore, 
there is consistency of the histologic patterns 
with those seen in inhalation-related injury. The 
frequency of small airways disease described in 
epidemiologic studies of WTC responders and 
the slow and relatively mild progression and 
long survival of the patients, which now appear 
to be exceeding survival of some with idiopathic 
interstitial lung disease, suggest that exposures at 
the WTC site might have caused these findings. 
Further follow-up of WTC-exposed individuals 
is critical to determine the overall health effects 
related to WTC exposure.
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